AI Article Synopsis
- - The study aimed to determine the average time patients with panretinal photocoagulation (PDR) take to develop vision-threatening retinopathy (VTR) complications after treatment, alongside identifying significant risk factors.
- - Records from 220 patients who underwent complete PRP were reviewed, revealing that the average duration from PRP to VTR was about 1.25 years, with specific risk factors like age, Black race, and diabetic foot disease (DFD) significantly impacting this timeline.
- - The findings suggest that DFD and Black race are important indicators for predicting the onset of VTR within 4 years post-PRP treatment, helping healthcare providers make better decisions in clinical practice.
Article Abstract
Background And Objective: To report the time in which patients with panretinal photocoagulation (PDR) progress to vision-threatening retinopathy (VTR) complications after receiving PRP, and risk factors in routine clinical practice.
Patients And Methods: Records of patients with complete PRP for PDR were retrospectively reviewed for up to 3.5 years after PRP. Two hundred twenty eyes were selected.
Results: Time from PRP to VTR was 1.25 ± 0.82 years. Age, Black race, neovascularization of the disc on examination, diabetic foot disease (DFD), and high-risk PDR characteristics on fluorescein angiography were identified as significant risk factors. Half of patients with DFD on examination developed a VTR within 1.5 years after PRP ( < .001).
Conclusion: In clinical practice, providers may consider DFD and Black race as predictors of time to VTR event within 4 years after PRP in patients with PDR. .
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3928/23258160-20220316-03 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Split-Mouth Comparison Between Platelet-Rich Plasma and Lymphomyosot for Management of the Postoperative Sequelae After the Extraction of Impacted Third Molars: A Case Report.
Cureus
November 2024
Department of Oral Surgery, Medical University of Varna, Varna, BGR.
Third molar extraction is one of the most common interventions in oral surgery. It is usually associated with postoperative pain, edema, and trismus. The severity of these sequelae can be related to the amount of surgical trauma and the duration of the extraction.
View Article and Find Full Text PDFAssessing Standardisation in Platelet-Rich Plasma (PRP) Injections for the Management of Greater Trochanteric Pain Syndrome (GTPS): A Systematic Review of the Available Literature.
Cureus
November 2024
Trauma and Orthopaedics, Queen Elizabeth Hospital Birmingham, Birmingham, GBR.
Greater trochanteric pain syndrome (GTPS) is a prevalent musculoskeletal condition characterised by lateral hip pain and reduced function. Platelet-rich plasma (PRP) injections have gained attention as a potential treatment due to their regenerative properties. However, variability in PRP preparation methods and insufficient standardisation in the literature complicate the evaluation of its efficacy and reproducibility.
View Article and Find Full Text PDFPart 1: Evaluation of Pediatric Cannabis-Drug Interaction Reports.
Pharmacol Res Perspect
February 2025
School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Data addressing safety concerns related to potential drug interactions between cannabis-derived products and pharmaceutical medications in the pediatric population are lacking. In this study, we retrieved case reports through a published literature search using PubMed and spontaneous reporting data using the Food and Drug Administration's Adverse Event Reporting System (FAERS) to identify potential cannabis- and cannabinoid-drug interactions in individuals younger than 18 years old. To evaluate the published case reports, we used the Drug Interaction Probability Scale (DIPS), a 10-item questionnaire designed to discern the causal relationship between a potential drug interaction and adverse drug reactions (ADRs).
View Article and Find Full Text PDF[Therapeutic effect of joint injection of platelet-rich plasma combined with shock wave on osteochondral injury of talus].
Zhongguo Gu Shang
December 2024
Department of Radiology, Sichuan Orthopaedic Hospital, Chengdu 610041, Sichuan, China.
Objective: To explore clinical efficacy of platelet rich plasma (PRP) injection combined with extracorporeal shock wave therapy (ESWT) in treating osteochondral lesion of talus (OLT) with typeⅡa.
Methods: From January 2022 to June 2022, 45 patients with typeⅡa OLT were treated with PRP arthroscopic injection combined with ESWT, including 29 males and 16 females; aged from 18 to 63 years old with an average of(37.7±10.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!